Update on Fiasp insulin 17 August 2023 Diabetes Australia have been consistently talking with both the Federal Government and Novo Nordisk about the need for a solution before 1 October 2023. We have been advised that negotiations are continuing. Both the Government and the manufacturer have been made aware of the significant angst this is causing the diabetes community Diabetes Australia will continue to advocate on this issue. We have set up a page – Fight for Fiasp – where you can lend your voice and advocate on this issue. We will keep you updated, as and when we hear anything on this issue.
Media releases 13 May 2025 The time is now for clear labelling of sugar content on sugary drinks Diabetes Australia is proud to stand with the Rethink Sugary Drink Alliance in today’s call for mandatory labelling of teaspoons... Continue Reading
Media releases 30 April 2025 Melbourne to host International Diabetes Congress amid rising health crisis In a major win for Australia’s diabetes community, the International Diabetes Federation Western Pacific Region (IDF WPR) Congress 2026 will... Continue Reading
News 3 April 2025 Public warning: Counterfeit Ozempic pens detected in Australia The Therapeutic Goods Administration (TGA) is urging the diabetes community to remain alert following the detection of counterfeit Ozempic-labelled injection... Continue Reading
